Search Medical Condition
Please enter condition
Please choose location from dropdown

Liuying Township, Taiwan Clinical Trials

A listing of Liuying Township, Taiwan clinical trials actively recruiting patients volunteers.

RESULTS

Found (55034) clinical trials

The Kentucky Neuroscience Institute is conducting a study to learn how the 2020 Coronavirus pandemic (COVID-19) has affected people. We are studying the psychological, social, physical, and emotional effects of social/physical distancing during this time, and what activities people are engaging in. People who complete the 30-minute survey can enter …

Phase N/A

Qualified participants will receive: Study-related medication at no cost Study-related medical exams at no cost Compensation for time and travel  Insurance is not needed to participate in this study.  

Phase N/A

Qualified participants will receive: Study-related medication at no cost Study-related medical exams at no cost Compensation for time and travel  

Phase N/A

Qualified participants will receive: Study-related medication at no cost Study-related medical exams at no cost Compensation for time and travel Insurance is not needed to participate in this study.

Phase N/A

Qualified participants will receive: Study-related medication at no cost Study-related medical exams at no cost Compensation for time and travel  Insurance is not needed to participate in this study.  

Phase N/A

Financial compensation may be provided for time and travel expenses.

Phase N/A

Financial compensation will be provided for time and travel expenses.

Phase N/A

The purpose of this study is to evaluate the safety and efficacy of pemigatinib plus pembrolizumab or pemigatinib alone versus the standard of care for participants with metastatic or unresectable urothelial carcinoma who are not eligible to receive cisplatin, are harboring FGFR3 mutation or rearrangement, and who have not received …

Phase

The purpose of this study is to determine the safety, tolerability, and efficacy of INCAGN01876 when given in combination with immune therapies in subjects with advanced or metastatic malignancies.  

Phase